NCT02164266View on ClinicalTrials.gov

A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy Volunteer, Type 2 Diabetes
Interventions
DRUG

Placebo

Matching placebo daily oral administration

DRUG

RO6799477

Daily oral administration of RO6799477

Trial Locations (1)

2333

Leiden

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02164266 - A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477 | Biotech Hunter | Biotech Hunter